tiprankstipranks

Andrew Ritter Insider Profile

4 Followers
Andrew Ritter, CEO & President, Director at Qualigen Therapeutics, holds 82.35K shares in Qualigen Therapeutics (Ticker: QLGN). Most recently, Andrew Ritter Sold $18,750 shares of Qualigen Therapeutics on Mar 13, 2020 for an estimated value of 6.94K.
tipranks
Andrew Ritter

Andrew Ritter
Qualigen Therapeutics (QLGN)
CEO & President, Director

Ranked #27,445 out of 98,909 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+64.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$24K
100.00%
A breakdown of Andrew Ritter's holdings

Insider Roles

Qualigen Therapeutics
(QLGN)
CEO & President, Director
Roles that Andrew Ritter holds in companies

Most Profitable Insider Trade

Stock:
Qualigen Therapeutics
(QLGN)
Rating:Informative Buy
Date:Feb 24, 2016 - Feb 24, 2017
Return:+86.40%
The most profitable trade made by Andrew Ritter

Andrew Ritter's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Qualigen Therapeutics
Mar 13, 2020
CEO & President, Director
Informative Sell
6.94K
$23.72K
Success Rate for
QLGN
2 out of 2 profitable transactions on
QLGN
100%
Average Return for
QLGN
Average return per transaction on
QLGN
+64.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 27, 2017
Uninformative Buy
$0.00
-
$0.00
Mar 13, 2020
Informative Sell
$6.94K
-
$0.37
+42.00%
Jun 30, 2015
Uninformative Buy
$0.00
-
$0.00
Feb 24, 2016
Informative Buy
$10.00K
-
$1.60
+86.40%
List of latest transactions for each holding click on a transaction to see Andrew Ritter's performance on stock

Andrew Ritter insider profile FAQ

What is the percentage of profitable transactions made by Andrew Ritter?
The percentage of profitable transactions made by Andrew Ritter is 100%.
    What is the average return per transaction made by Andrew Ritter?
    The average return per transaction made by Andrew Ritter is 64.20%.
      What stocks does Andrew Ritter hold?
      Andrew Ritter holds: QLGN stocks.
        What was Andrew Ritter’s latest transaction?
        Andrew Ritter latest transaction was an Informative Sell of $6.94K.
          What was Andrew Ritter's most profitable transaction?
          Andrew Ritter’s most profitable transaction was an Informative Buy of QLGN stock on February 24, 2016. The return on the trade was 86.40%.
            What is Andrew Ritter's role in Qualigen Therapeutics?
            Andrew Ritter's role in Qualigen Therapeutics is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.